Jiangsu Yuyue Medical Equipment & Supply (002223) Q1 2026 earnings summary

Executive summary

• Revenue for Q1 2026 was ¥2.37 billion, down 2.69% year-over-year; net profit attributable to shareholders was ¥428 million, down 31.44% year-over-year.

• Cash flow from operating activities was ¥597 million, a decrease of 9.21% compared to the same period last year.

• Significant product milestones include EU MDR certification for the CGM system and regulatory approval for a semi-automatic external defibrillator.

Financial highlights

• Revenue decreased 2.69% year-over-year; net profit attributable to shareholders fell 31.44%.

• Net profit excluding non-recurring items was ¥410 million, down 20% year-over-year.

• Basic and diluted EPS were ¥0.4291, down 31.57% year-over-year.

• Total assets at quarter-end were ¥16.89 billion, up 5% from year-end 2025.

• Owner's equity attributable to shareholders rose 3.09% from year-end 2025.

Key financial ratios and metrics

• Weighted average ROE was 3.19%, down 1.68 percentage points year-over-year.

• Gross margin and operating margin not explicitly stated, but net profit margin declined.